CSO and Immunologist; interested in ML and Agentic AI applied to Target and Drug Discovery, but above all in life and its colorful surprises
United Kingdom
Joined June 2019
- Tweets155
- Following739
- Followers262
- Likes264
A very warm welcome to the new CEO of the @britsocimm Graham Blair !@Grayblair101
We’re delighted to announce that Graham Blair will be joining the BSI as our new Chief Executive, starting 3 Nov 2025 🎉
With a wealth of leadership experience, Graham will help us champion immunology & strengthen our community: immunology.org/news/bsi-anno…
Edith M Hessel PhD retweeted
🚨 A new £50M @The_MRC Centre at @FBMH_UoM and @UniofOxford will explore how pollution, microbes & other environmental exposures rewire our immune system and cause chronic inflammatory diseases.
sites.manchester.ac.uk/lydia…
Many congratulations to my teo colleagues, so well-deserved Prof Deborah Dunn-Walters @beecellnumbers and Prof Clare Bryant @ClareBryant13 🚀🚀
🌟 BSI success stories!
Three of our members have been elected Fellows of the Academy of Medical Sciences 2025, including a BSI Trustee, Deborah - @beecellnumbers, whose leadership inspires the immunology community.
Read more about their achievements 👉 bit.ly/452MeVz
Great work from the Zou Lab - a truly AI-designed molecule against S. aureus @james_y_zou #MRSA #AgenticAI
>700K people die each year due to S. aureus infection.
Today we show that our AI designed new molecule, synthecin, stops drug-resistant S. aureus MRSA in mouse model💊
We created synthecin w/ SyntheMol-RL, our new RL generative AI. All open source biorxiv.org/content/10.1101/…
Edith M Hessel PhD retweeted
🧬 @RelationRx partners with @GSK to tackle fibrotic #diseases and osteoarthritis – advancing drug discovery for millions in need ➡️ ow.ly/fu1550UpZxv
Their cutting-edge platform and GSK’s expertise aim to deliver transformative #medicines.
Incredibly delighted to be part of the Kennedy Trust Board. The high quality work and people funded by the trust paves the way to new therapeutic opportunities for patients! @TheKennedyTrust @KirOxford
We’re delighted to welcome four new Trustees to the Kennedy Trust’s Board: Professor Paul Peter Tak @paulpetertak, Dr Edith Hessel @HesselEdith, Professor Paul Emery and Dr Tony Wood! Read more on our website 👇
kennedytrust.org/2024-truste…
Edith M Hessel PhD retweeted
In likely the largest deal ever for a seed-stage biotech/techbio company, @DCVC-backed @RelationRx and @GSK will seek to create a new gen of drugs for fibrotic disease and osteoarthritis. Big congrats to both companies!
More from DCVC GP @jason_pontin 👇
bit.ly/3ZunHo3
Brilliant news! @RelationRx linkedin.com/posts/edith-hes…
Looking forward to seeing you @NeurIPSConf with my colleagues from @RelationRx Lindsay Edwards, Hagen Triendle, Anna Gogleva, and Rosie Rodriguez. @doctordindsay @TriendlHagenRel
📅 Sunday, Dec 15th - From 14:15–15:00
NVIDIANs will join @doctordindsay and @HesselEdith from @RelationRx for an engaging panel discussion at the “AI for New Drug Modalities Workshop"
sites.google.com/view/newmod…
Looking forward to Paul Peter’s keynote lecture today and the Immune Therapies Summit #ImmuneTherapies24 @britsocimm
Edith M Hessel PhD retweeted
LAST CHANCE to secure reduced registration fees for BSI #ImmuneTherapies24 ⏰
This event will bring together #clinical, academic and #industry thought leaders including keynote speaker Dr @paulpetertak 🌟
Don't miss out! Register TODAY (31 Oct) 🔗bit.ly/4eYp306
Edith M Hessel PhD retweeted
Have you ever wondered which single cell/spatial omic technology to use? There's lots of methods developed in academia, but no review of marketed products.
Check the @scTrends_update (sctrends.org/) commentary in @NatureBiotech by @wildtypehuman & @AdamCribbs
The July issue is live nature.com/nbt/volumes/42/is…
Our cover shows a DNA nanodevice measuring organellar sodium ion levels in lysosomes of living cells. Zou et al. developed RatiNa for imaging intracellular Na⁺ at single-organelle resolution go.nature.com/3Zqfl04
May is #OsteoporosisAwareness month. At @RelationRx, we use our Large Language Model & high dimensional patient data to shine a bright light on the mechanisms that underpin disease in these underserved patients. Our aim is to develop novel therapeutics. #ThePatientIsWaiting
Osteoporosis impacts millions of Americans. According to @bonehealthBHOF, one in two women and one in four men will break a bone due to osteoporosis. #OsteoporosisAwareness
Many thanks @Emma_S_Chambers for an impactful 6 years of your time at the BSI Board, representing the Early Career Researchers along with Calum Bain @bainlab inviting us to consider new approaches to support those at the start of their careers in Immunology. #BSI
Today is my last board meeting as @britsocimm trustee. I have spent six wonderful years representing ECRs - I am incredibly proud of ECR initiatives brought in by the BSI, such as the Career Enhancement Grants immunology.org/membership/gr…. Thanks to the trustees past and present.
Edith M Hessel PhD retweeted
AI & Biology/medicine is at its best time 🔥🔥exciting time ahead! – at Vaughan, Ontario
Many thanks to @anthonycosta for his excellent chairing. It was a great pleasure to be part of this panel at #GTC24, along with my co-panelist @NaefLuca @DaphneKoller and Gary Glick on behalf of @RelationRx.
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm | BioSpace biospace.com/article/release… #jobs
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm uk.finance.yahoo.com/news/re…
Edith M Hessel PhD retweeted
Interrogating LLMs for causal bio pathways may be a new frontier in discovering future cures.
Relation Tx (disclosure: I cofounded & chair) just announced an amazing syndicate of investors to complete the $60M Seed: DCVC, Deerfield, NVIDIA, Magnetic. EndPts exclusive below👇.
Hugely happy for the incredible team, and the visionary investors making this possible, incl. @zackbogue, @jason_pontin : @DCVC who led the new $35M to complete the Seed, Magnetic Ventures (led prior). New joiners @nvidia, plus Deerfield, one of the world's leading biotech investors, and Khosla, @vkhosla @genomicsdoc, also backers of OpenAI/ChatGPT.
Most all, excited for the potential to deliver previously impossible life-enhancing therapies to 🦴patients.
endpts.com/relation-raises-3…
Edith M Hessel PhD retweeted
We are excited to share our latest paper @CellPressNews on RECOVER which was co-led by our CIO Jake Taylor-King @wildtypehuman and Yoshua Bengio @Mila_Quebec
#cause2cure #patientiswaiting
lnkd.in/eQXacmWS
